Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marcellin

Showing results (141-150 of 212) with videos related to

Pageof 22
Sort By:
Journal of Hepatology|April 27, 2001
Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trialJ P Zarski, K Barange, C Souvignet, et al.
Journal of Hepatology|August 8, 1998
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric methodV Duchatelle, P Marcellin, E Giostra, et al.
Journal of Viral Hepatitis|January 1, 1997
Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosisP Marcellin, N Giuily, M A Loriot, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activityS Zeuzem, A Alberti, W Rosenberg, et al.
Hepatology (Baltimore, Md.)|September 1, 1989
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patientsP Marcellin, D Ouzan, F Degos, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CM Martinot-Peignoux, P Marcellin, M Pouteau, et al.
Digestive Diseases and Sciences|December 1, 1993
Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their childrenP Marcellin, J Bernuau, M Martinot-Peignoux, et al.
Liver|December 1, 1993
Hepatitis C virus infection in anti-HIV positive and negative French homosexual men with chronic hepatitis: comparison of second- and third-generation anti-HCV testingP Marcellin, J F Colin, M Martinot-Peignoux, et al.
Journal of Medical Virology|April 1, 1995
Hepatitis C virus genotypes in French blood donorsJ Gournay, P Marcellin, M Martinot-Peignoux, et al.
Journal of Hepatology|December 1, 1994
Fatal reactivation of hepatitis B virus mutant following cytotoxic treatmentJ C Duclos-Vallee, P Laurent-Puig, M A Loriot, et al.
Pageof 22

Showing results (141-150 of 212) with videos related to

Sort By:
Pageof 22
Journal of Hepatology|April 27, 2001
Efficacy and safety of lactosaminated human serum albumin-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trialJ P Zarski, K Barange, C Souvignet, et al.
Journal of Hepatology|August 8, 1998
Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric methodV Duchatelle, P Marcellin, E Giostra, et al.
Journal of Viral Hepatitis|January 1, 1997
Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosisP Marcellin, N Giuily, M A Loriot, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2006
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activityS Zeuzem, A Alberti, W Rosenberg, et al.
Hepatology (Baltimore, Md.)|September 1, 1989
Randomized controlled trial of adenine arabinoside 5'-monophosphate in chronic active hepatitis B: comparison of the efficacy in heterosexual and homosexual patientsP Marcellin, D Ouzan, F Degos, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CM Martinot-Peignoux, P Marcellin, M Pouteau, et al.
Digestive Diseases and Sciences|December 1, 1993
Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their childrenP Marcellin, J Bernuau, M Martinot-Peignoux, et al.
Liver|December 1, 1993
Hepatitis C virus infection in anti-HIV positive and negative French homosexual men with chronic hepatitis: comparison of second- and third-generation anti-HCV testingP Marcellin, J F Colin, M Martinot-Peignoux, et al.
Journal of Medical Virology|April 1, 1995
Hepatitis C virus genotypes in French blood donorsJ Gournay, P Marcellin, M Martinot-Peignoux, et al.
Journal of Hepatology|December 1, 1994
Fatal reactivation of hepatitis B virus mutant following cytotoxic treatmentJ C Duclos-Vallee, P Laurent-Puig, M A Loriot, et al.
Pageof 22